ClinicalTrials.Veeva

Menu

Prediction for Bronchopulmonary Dysplasia

K

Kai Mu

Status

Unknown

Conditions

Bronchopulmonary Dysplasia

Treatments

Other: occurrence of bronchopulmonary dysplasia

Study type

Observational

Funder types

Other

Identifiers

NCT05181319
QFS-2018-1201

Details and patient eligibility

About

In this Multi-center study performed from January 2018, we reviewed data on infants whose gestational ages were below 36 weeks. we collected data containing maternal diseases and neonatal clinical features. LASSO regression was used to select variables for the risk model. Then, we used multivariable logistic regression to build the prediction model incorporating these selected features. Discrimination was assessed by the C-index, and and calibration of the model was assessed by and calibration curve and the Hosmer-Lemeshow test.

Enrollment

5,000 estimated patients

Sex

All

Ages

Under 1 day old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients were recruited from Multi-center Collaborative Group Hospital Neonatal Intensive Care Unit (NICU) Department.
  • Patients with gestational age <36 weeks
  • admitted to the NICU within 24 h after birth
  • the length of stay was more than 1 week

Exclusion criteria

  • patients with inherited disease, metabolic disorders and multiple malformations.

Trial design

5,000 participants in 2 patient groups

bronchopulmonary dysplasia group
Description:
infants diagnosed with bronchopulmonary dysplasia
Treatment:
Other: occurrence of bronchopulmonary dysplasia
no bronchopulmonary dysplasia
Description:
infants not diagnosed with bronchopulmonary dysplasia
Treatment:
Other: occurrence of bronchopulmonary dysplasia

Trial contacts and locations

1

Loading...

Central trial contact

ZHANG Jing; MU Kai, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems